Meditech International Inc. initiated research in the development of Low Intensity Laser Therapy Systems in 1989. The objective of the company has been to engineer devices that are superior to those in existence and to scientifically develop safe, accurate and effective protocols to treat a variety of medical conditions in the musculoskeletal field. Whereas initially we restricted treatment to problems in that area over the course of the years, we have included sports injuries, arthritis, wound healing and dermatological conditions etc. In most instances, these conditions are highly responsive to laser therapy, as our protocols have become more focused and refined.

At this time, in going forward, we are also researching therapeutic initiatives involving the organs and systemic problems. Early results in this area of research have been most productive. To date, we continue to exceed our initial goals and expectations. Each day advances our horizons, as the research and educational process continues. Our basic objectives are to significantly improve/cure the multiple pathologies that we encounter in the shortest possible period of time. Guidelines to that end consist of the elimination of pain and pharmaceuticals and the restoration of normal mobility and quality of life. 

Fred Kahn MD FRCS(C), Dipl ABS
Founder, Meditech International Inc..